Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Use of a Digital Medication Management System for Effective Assessment and Enhancement of Patient Adherence to Therapy (ReX): Feasibility Study.

Shtrichman R, Conrad S, Schimo K, Shachar R, Machluf E, Mindal E, Epstein H, Epstein S, Paz A.

JMIR Hum Factors. 2018 Nov 26;5(4):e10128. doi: 10.2196/10128.

2.

Clinical Evaluation of a Novel Technology for Oral Patient-Controlled Analgesia, the PCoA® Acute Device, for Hospitalized Patients with Postoperative Pain, in Pilot Feasibility Study.

Wirz S, Conrad S, Shtrichman R, Schimo K, Hoffmann E.

Pain Res Manag. 2017;2017:7962135. doi: 10.1155/2017/7962135. Epub 2017 Sep 28.

3.

GeneAnalytics: An Integrative Gene Set Analysis Tool for Next Generation Sequencing, RNAseq and Microarray Data.

Ben-Ari Fuchs S, Lieder I, Stelzer G, Mazor Y, Buzhor E, Kaplan S, Bogoch Y, Plaschkes I, Shitrit A, Rappaport N, Kohn A, Edgar R, Shenhav L, Safran M, Lancet D, Guan-Golan Y, Warshawsky D, Shtrichman R.

OMICS. 2016 Mar;20(3):139-51. doi: 10.1089/omi.2015.0168.

4.

Cell-based therapy approaches: the hope for incurable diseases.

Buzhor E, Leshansky L, Blumenthal J, Barash H, Warshawsky D, Mazor Y, Shtrichman R.

Regen Med. 2014;9(5):649-72. doi: 10.2217/rme.14.35. Review.

PMID:
25372080
5.

The generation of hybrid electrospun nanofiber layer with extracellular matrix derived from human pluripotent stem cells, for regenerative medicine applications.

Shtrichman R, Zeevi-Levin N, Zaid R, Barak E, Fishman B, Ziskind A, Shulman R, Novak A, Avrahami R, Livne E, Lowenstein L, Zussman E, Itskovitz-Eldor J.

Tissue Eng Part A. 2014 Oct;20(19-20):2756-67. doi: 10.1089/ten.TEA.2013.0705.

PMID:
25185111
6.

ADAR1 is involved in the regulation of reprogramming human fibroblasts to induced pluripotent stem cells.

Germanguz I, Shtrichman R, Osenberg S, Ziskind A, Novak A, Domev H, Laevsky I, Jacob-Hirsch J, Feiler Y, Rechavi G, Itskovitz-Eldor J.

Stem Cells Dev. 2014 Mar 1;23(5):443-56. doi: 10.1089/scd.2013.0206. Epub 2013 Dec 14.

PMID:
24192045
7.

LifeMap Discovery™: the embryonic development, stem cells, and regenerative medicine research portal.

Edgar R, Mazor Y, Rinon A, Blumenthal J, Golan Y, Buzhor E, Livnat I, Ben-Ari S, Lieder I, Shitrit A, Gilboa Y, Ben-Yehudah A, Edri O, Shraga N, Bogoch Y, Leshansky L, Aharoni S, West MD, Warshawsky D, Shtrichman R.

PLoS One. 2013 Jul 17;8(7):e66629. doi: 10.1371/journal.pone.0066629. Print 2013.

8.

Induced pluripotent stem cells (iPSCs) derived from different cell sources and their potential for regenerative and personalized medicine.

Shtrichman R, Germanguz I, Itskovitz-Eldor J.

Curr Mol Med. 2013 Jun;13(5):792-805. Review.

PMID:
23642060
9.

Altered A-to-I RNA editing in human embryogenesis.

Shtrichman R, Germanguz I, Mandel R, Ziskind A, Nahor I, Safran M, Osenberg S, Sherf O, Rechavi G, Itskovitz-Eldor J.

PLoS One. 2012;7(7):e41576. doi: 10.1371/journal.pone.0041576. Epub 2012 Jul 31.

10.

Cardiomyocytes generated from CPVTD307H patients are arrhythmogenic in response to β-adrenergic stimulation.

Novak A, Barad L, Zeevi-Levin N, Shick R, Shtrichman R, Lorber A, Itskovitz-Eldor J, Binah O.

J Cell Mol Med. 2012 Mar;16(3):468-82. doi: 10.1111/j.1582-4934.2011.01476.x.

11.

Enhanced reprogramming and cardiac differentiation of human keratinocytes derived from plucked hair follicles, using a single excisable lentivirus.

Novak A, Shtrichman R, Germanguz I, Segev H, Zeevi-Levin N, Fishman B, Mandel YE, Barad L, Domev H, Kotton D, Mostoslavsky G, Binah O, Itskovitz-Eldor J.

Cell Reprogram. 2010 Dec;12(6):665-78. doi: 10.1089/cell.2010.0027. Epub 2010 Oct 21.

PMID:
20964482
12.

Alu sequences in undifferentiated human embryonic stem cells display high levels of A-to-I RNA editing.

Osenberg S, Paz Yaacov N, Safran M, Moshkovitz S, Shtrichman R, Sherf O, Jacob-Hirsch J, Keshet G, Amariglio N, Itskovitz-Eldor J, Rechavi G.

PLoS One. 2010 Jun 21;5(6):e11173. doi: 10.1371/journal.pone.0011173.

13.

Molecular characterization and functional properties of cardiomyocytes derived from human inducible pluripotent stem cells.

Germanguz I, Sedan O, Zeevi-Levin N, Shtrichman R, Barak E, Ziskind A, Eliyahu S, Meiry G, Amit M, Itskovitz-Eldor J, Binah O.

J Cell Mol Med. 2011 Jan;15(1):38-51. doi: 10.1111/j.1582-4934.2009.00996.x.

14.
15.

The role of gamma interferon in antimicrobial immunity.

Shtrichman R, Samuel CE.

Curr Opin Microbiol. 2001 Jun;4(3):251-9. Review.

PMID:
11378475
16.

Selection of apoptosis-deficient adenovirus E4orf4 mutants in Saccharomyces cerevisiae.

Afifi R, Sharf R, Shtrichman R, Kleinberger T.

J Virol. 2001 May;75(9):4444-7. Erratum in: J Virol 2001 Jun;75(12):5719.

17.

The adenovirus E4-ORF4 splicing enhancer protein interacts with a subset of phosphorylated SR proteins.

Estmer Nilsson C, Petersen-Mahrt S, Durot C, Shtrichman R, Krainer AR, Kleinberger T, Akusjärvi G.

EMBO J. 2001 Feb 15;20(4):864-71.

18.
20.

Induction of apoptosis by adenovirus E4orf4 protein is specific to transformed cells and requires an interaction with protein phosphatase 2A.

Shtrichman R, Sharf R, Barr H, Dobner T, Kleinberger T.

Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):10080-5.

21.

Supplemental Content

Loading ...
Support Center